Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05529758 · ClinicalTrials.gov registry record · NA
Virtual Third-Wave Intervention for Internalized Weight Bias Combined With a Weight Loss Program
A NA study, sponsored by East Carolina University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05529758: Completed NA study, sponsored by East Carolina University.
NCT05529758 is a NA study that has completed, run by East Carolina University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05529758, a NA study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The current study aims to test a third-wave based IWB intervention paired with a standard BWLP delivered through video conferencing software.
Primary Outcome
Weight Change
Interventions
- BEHAVIORAL Internalized Weight Bias Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
What the finished NCT05529758 record still lists
NCT05529758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Internalized Weight Bias Intervention is the first listed.
NCT05529758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05529758 about?
NCT05529758 is a clinical study titled "Virtual Third-Wave Intervention for Internalized Weight Bias Combined With a Weight Loss Program". The current study aims to test a third-wave based IWB intervention paired with a standard BWLP delivered through video conferencing software.
What is the current status of trial NCT05529758?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-08-15. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05529758?
The interventions under investigation include: Internalized Weight Bias Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05529758?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05529758's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI